Articles Tagged ‘biomarkers’

22
Jul
2010

Molecular Predictors of Prostate Cancer Progression and Mortality Co-Leaders: Janet Stanford, Ph.D., Daniel Lin, M.D. Prostate cancer (PCa) is a major cause of mortality, but it is not currently possible to accurately predict which tumors will remain indolent vs become life-threatening. To identify prognostic biomarkers, the proposed study will utilize samples and

07
Dec
2009
Bielas, Mostaghel secure three-year funding for prostate-cancer research

Drs. Elahe Mostaghel and Jason Bielas recently received New Investigator Awards from the Department of Defense’s Prostate Cancer Research Program. Bielas, an investigator in the Public Health Sciences Division, will use his three-year, $365,000 grant to develop a blood-based, non-invasive screening

23
May
2008

Pascal LE, True LD, Campbell DS, Deutsch EW, Risk M, Coleman IM, Eichner LJ, Nelson PS, Liu AY. Correlation of mRNA and protein levels: cell type-specific gene expression of cluster designation antigens in the prostate. BMC Genomics. 2008 May 23;9:246. PubMed PMID: 18501003. BACKGROUND:: Expression levels of mRNA and

05
May
2008
Dr. Nelson to lead Canary Foundation’s Prostate Consortium

Researchers at the Hutchinson Center have a lead role in a new public/private partnership to create the first systematic surveillance program of men with prostate cancer to look for biological clues to help determine when to wait and

01
Mar
2008

Lin B, Utleg AG, Gravdal K, White JT, Halvorsen OJ, Lu W, True LD, Vessella R, Lange PH, Nelson PS, Hood L, Kalland KH, Akslen LA. WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures